• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同胆囊收缩素受体的多种亲和状态。

Multiple affinity states of different cholecystokinin receptors.

作者信息

Huang S C, Fortune K P, Wank S A, Kopin A S, Gardner J D

机构信息

Department of Internal Medicine, St. Louis University Health Sciences Center, Missouri 63104.

出版信息

J Biol Chem. 1994 Oct 21;269(42):26121-6.

PMID:7929324
Abstract

We transfected COS cells with cDNA for rat cholecystokinin-A (CCK-A) and different CCK-B receptors and measured binding of 125I-CCK-8, [3H]L-364,718 and [3H]L-365,260 to characterize the different affinity states for each type of CCK receptor. Rat CCK-A and CCK-B receptors, canine CCK-B receptors and canine mutant CCK-B (M-CCK-B) receptors in which the leucine in position 355 was replaced by valine each existed in three different affinity states for CCK-8, high affinity, low affinity, and very low affinity. In rat CCK-A and probably CCK-B receptors, most were in the very low affinity state, whereas with canine CCK-B and M-CCK-B receptors, most were in the low affinity state. Studies with CCK receptor agonists, CCK-8, gastrin, and CCK-JMV-180, in conjunction with CCK receptor antagonists, L-364,718 and L-365,260, showed a different pattern of affinities for these ligands at the different CCK receptors. Thus, each transfected CCK receptor can exist in three different affinity states for CCK-8 and has a characteristic pattern of interaction with different ligands. This ability to exist in multiple affinity states is an intrinsic property of the CCK receptor molecule itself.

摘要

我们用大鼠胆囊收缩素-A(CCK-A)和不同的CCK-B受体的cDNA转染COS细胞,并测定125I-CCK-8、[3H]L-364,718和[3H]L-365,260的结合情况,以表征每种类型CCK受体的不同亲和状态。大鼠CCK-A和CCK-B受体、犬CCK-B受体以及第355位亮氨酸被缬氨酸取代的犬突变CCK-B(M-CCK-B)受体对CCK-8均存在三种不同的亲和状态,即高亲和、低亲和和极低亲和。在大鼠CCK-A受体以及可能的CCK-B受体中,大多数处于极低亲和状态,而犬CCK-B和M-CCK-B受体中,大多数处于低亲和状态。使用CCK受体激动剂CCK-8、胃泌素和CCK-JMV-180,结合CCK受体拮抗剂L-364,718和L-365,260进行的研究表明,这些配体在不同CCK受体上具有不同的亲和模式。因此,每种转染的CCK受体对CCK-8可存在三种不同的亲和状态,并且与不同配体具有独特的相互作用模式。这种存在多种亲和状态的能力是CCK受体分子本身的固有特性。

相似文献

1
Multiple affinity states of different cholecystokinin receptors.不同胆囊收缩素受体的多种亲和状态。
J Biol Chem. 1994 Oct 21;269(42):26121-6.
2
Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.胰腺腺泡中胆囊收缩素(CCK)受体三种不同状态的特征描述。
Biochim Biophys Acta. 1994 Oct 20;1224(1):103-16. doi: 10.1016/0167-4889(94)90118-x.
3
Direct demonstration of three different states of the pancreatic cholecystokinin receptor.胰腺胆囊收缩素受体三种不同状态的直接证明。
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1868-72. doi: 10.1073/pnas.91.5.1868.
4
Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.胰腺腺泡中胆囊收缩素(CCK)受体三种不同状态的生化调节。
Biochim Biophys Acta. 1994 Oct 20;1224(1):117-26. doi: 10.1016/0167-4889(94)90119-8.
5
The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding.胃泌素/胆囊收缩素受体的第七个跨膜结构域有助于非肽拮抗剂结合。
Biochem Biophys Res Commun. 1994 Jun 30;201(3):1382-9. doi: 10.1006/bbrc.1994.1856.
6
Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.使用全肽拮抗剂JMV 179对大鼠胰腺胆囊收缩素受体的状态和数量进行研究。
Eur J Biochem. 1993 Mar 1;212(2):529-38. doi: 10.1111/j.1432-1033.1993.tb17690.x.
7
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.(3R)-N-(1-(叔丁基羰基甲基)-2,3-二氢-2-氧代-5-(2-吡啶基)-1H-1,4-苯并二氮杂䓬-3-基)-N'-(3-(甲氨基)苯基)脲(YF476):一种强效口服活性胃泌素/CCK-B拮抗剂。
J Med Chem. 1997 Jan 31;40(3):331-41. doi: 10.1021/jm960669+.
8
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.YF476是一种新型的强效且选择性的胃泌素/胆囊收缩素-B受体拮抗剂,在体内和体外均有此特性。
Aliment Pharmacol Ther. 1997 Feb;11(1):113-20. doi: 10.1046/j.1365-2036.1997.110281000.x.
9
CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.胆囊收缩素拮抗剂与人类小细胞肺癌细胞上的胆囊收缩素B受体相互作用。
Peptides. 1990 Sep-Oct;11(5):1033-6. doi: 10.1016/0196-9781(90)90029-5.
10
Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.胆囊收缩素-B/胃泌素受体配体“口袋”内的突变可使非肽类激动剂和拮抗剂的功能相互转换。
Mol Pharmacol. 1998 Nov;54(5):857-63. doi: 10.1124/mol.54.5.857.

引用本文的文献

1
Non-sulfated cholecystokinin-8 increases enteric and hindbrain Fos-like immunoreactivity in male Sprague Dawley rats.非硫酸化胆囊收缩素-8 增加雄性 Sprague Dawley 大鼠的肠和后脑 Fos 样免疫反应。
Brain Res. 2019 Apr 1;1708:200-206. doi: 10.1016/j.brainres.2018.12.019. Epub 2018 Dec 17.
2
Protein kinase C isoforms in the normal pancreas and in pancreatic disease.蛋白激酶 C 同工型在正常胰腺和胰腺疾病中的作用。
Cell Signal. 2017 Dec;40:1-9. doi: 10.1016/j.cellsig.2017.08.005. Epub 2017 Aug 18.
3
Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
人类脑肠肽受体的比较药理学:铃蟾素受体亚型-3、非肽类激动剂 MK-5046、通用肽类激动剂和肽类拮抗剂 Bantag-1。
J Pharmacol Exp Ther. 2013 Oct;347(1):100-16. doi: 10.1124/jpet.113.206896. Epub 2013 Jul 26.
4
Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.对1型和2型胆囊收缩素受体具有选择性的放射性碘化苯二氮䓬类化合物的合成及体外特性研究
J Med Chem. 2009 Apr 9;52(7):2138-47. doi: 10.1021/jm801439x.
5
New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454.新型CCK2激动剂证实CCK2受体的异质性:BBL454的特性研究
Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):404-13. doi: 10.1007/s00210-004-0969-7. Epub 2004 Oct 8.
6
Influence of cholecystitis state on pharmacological response to cholecystokinin of isolated human gallbladder with gallstones.胆囊炎状态对伴有胆结石的离体人胆囊对胆囊收缩素的药理反应的影响。
Dig Dis Sci. 2003 May;48(5):898-905. doi: 10.1023/a:1023091327412.
7
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.胆囊收缩素-A受体结合位点的精氨酸197与肽激动剂胆囊收缩素的硫酸盐相互作用。
Protein Sci. 1999 Nov;8(11):2347-54. doi: 10.1110/ps.8.11.2347.
8
Interactions between cholecystokinin and opioids in the isolated guinea-pig ileum.胆囊收缩素与阿片类药物在离体豚鼠回肠中的相互作用。
Br J Pharmacol. 1999 Jun;127(4):909-18. doi: 10.1038/sj.bjp.0702621.
9
Cholecystokinin receptors.胆囊收缩素受体
Cell Mol Neurobiol. 1995 Oct;15(5):545-59. doi: 10.1007/BF02071316.
10
Modulation of cholecystokinin activity by albumin.白蛋白对胆囊收缩素活性的调节作用。
Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10312-6. doi: 10.1073/pnas.92.22.10312.